Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
a duration of less than a year. This plan should be based on scientific justification given the expertise and infrastructure at both institutions. This plan can be changed during the program upon
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
both computational and experimental biology to join our team in reimagining how we discover and deploy drug combinations in the clinic. Our work is highly interdisciplinary, integrating high-throughput
-
responses to odor stimuli directly from the human olfactory receptors. Your main tasks will be, with the help of research assistants, to develop the recording setup, design and conduct experiments, analyze
-
) and related to the major multi-national initiative “GOE-DEEP” supported by the International Continental Scientific Drilling Program (ICDP) and aiming to study the climate at the time of the first rise
-
do · An environment encouraging curiosity, innovation and entrepreneurship in all areas · Personalized learning programme to foster our staff’s soft and technical skills
-
includes the following tasks: Develop computer-aided design software for modular construction of switchable RNA nanostructures. Develop databases for RNA modules for automated building of atomistic models
-
transcriptomics, untargeted metabolomics, quantitative proteomics. Computational and AI approaches: microprotein bioinformatics, multi‑omic integration, protein language models, generative sequence design, and
-
including protein purification, enzymology and protein design/engineering. Your profile Applicants should hold a Ph.D.’s degree in Biology and have experience in engineering sugar binding proteins and be
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19